Arch Venture Partners

Sobre

ARCH Venture Partners is a specialist life-science and deep-technology company builder that co-founds businesses from scientific discoveries and supports them through growth. ARCH states that it has invested from as little as $50K to hundreds of millions of dollars per company. The firm primarily forms and leads companies from inception, and closed a $3B+ Fund XIII in 2024.

Sectores

• Ciencias de la vida
• Deep tech

Inversiones destacadas

• Illumina
• Alnylam Pharmaceuticals
• Agios Pharmaceuticals
• Denali Therapeutics
• Twist Bioscience
• Vir Biotechnology
• Beam Therapeutics
• Sana Biotechnology

Inversores

• Ari NowacekPartner→
• Brian CuneoSenior Partner→
• Carol SuhPartner→
• Corey RitterPartner→
• David MooreSenior Partner→
• Keith CrandellCo-Founder & Managing Director→
• Kristina BurowManaging Director→
• Mark McDonnellManaging Director→
• Nilay ThakarPrincipal→
• Paul BernsManaging Director→
• Peter MintunAssociate→
• Robert NelsenCo-Founder & Managing Director→
• Sean KendallPartner, Europe→
• Steve GillisManaging Director→

Cómo contactarlos

emailinquiries@archventure.com